An overview of size reduction technologies in the field of pharmaceutical manufacturing

Main Article Content

Rakesh P Patel
Ashok H Baria
Nikunjana A Patel


Size reduction is a process of reducing large solid unit masses into small unit masses, coarse particles or fine particles. Size reduction process is also termed as comminution or diminution or pulverizations. In addition to the standard adjustments of the milling process (i.e., speed, screen size, design of rotor, load), special techniques of milling may be useful including special
atmosphere, temperature control, sonocrystallization, supercritical fluid process. etc. Moreover, some advance technologies of size reduction including Micron Technologies, Gran-U-LizerTM Technology, Jet-O-MizerTM and Microfluidics® have
been popular. Various application of size reduction concept covers oral delivery of poorly soluble drugs, micronization, nanotechnology (micro- and nano suspensions), etc.This systemic review highlights advantages and disadvantages, mechanisms, theories, techniques, advances, and pharmaceutical applications of size reduction technology.


Download data is not yet available.

Article Details

How to Cite
Patel, R. P., Baria, A. H., & Patel, N. A. (2014). An overview of size reduction technologies in the field of pharmaceutical manufacturing. Asian Journal of Pharmaceutics (AJP), 2(4).


Abouzeid AZ. Processing of fine particles in mineral beneficiation. Part

Powder Handling and Processing 1994;6:35-48.

Price M. Size reduction. In: Othmer K, editor. Encyclopedia of chemical

technology. New York: John Wiley and Sons; 1999. p. 836-8.

Rudd DF, Powers GJ, Siirola JJ. ‘Process synthesis’. Englewood Cliffs,

N.J.: Prentice-Hall; 1973, 205-208,

Subramanyam CV. ‘Size reduction’. In: Pharmaceutical Engineering. 1st

ed. Vallabh Prakashan; 2004. p. 144-76.

Jani GK. ‘Size Reduction’. In: Pharmaceutical Engineering-II. 2nd ed.

B.S. Shah Prakashan; 2005. p. 1-30.

Parrot EL. ‘Milling’ In: Lachman L, editor. The Theory and practice of

Industrial Pharmacy. 3rd ed. Varghese Publisher Housing; 1990. p.


Parrot EL. ‘Size Reduction’. In: Swwbrick J, Boyalan JC, editors.

‘Encyclopedia of Pharmaceutical Technology’. New York: Marcel Dekker

Inc; 1998. p. 101-20.

O’Connor RE, Schwartz JB, ‘Powder’. In: Gennaro AR, editor. Remington:

The science and practice of pharmacy. USA: Lippincott Williams and

Wilkins; 2001. p. 681-99.

Staniforth J. ‘Size Reduction’. In: Aulton ME, editor. The Science of

Dosage Form Design. London: Churchill Livingstone; 2nd ed. 2005. p.


Cooper and Gun. ‘Size Reduction’. In: Carter SJ, editor. Tutorial

Pharmacy. 6th ed. 2000. p. 183-91.

Bond FC. Chemical Engineering. 1952. p. 59-169.

Snow RH, Kaye BH, Capes CE, Srety GC. ‘Size reduction and size

enlargement’. In: Perry RH, Green D, editors. Chemical Engineers

Handbook. McGraw Hill International; 1963. p. 1-72.

Othmer K. Encyclopedia of chemical technology. New York: John Wiley

and Sons; 2002. p. 18,336.

Berry CE. Modern machines for dry size reduction in fine size range.

Indian Eng Chem 1946;38:672.

Banga S, Chawla G, Bansal AK. New trends in the crystallisation of

active pharmaceutical ingredients, Business briefing. Pharmagenerics


Crystallization process using ultrasound. United States Patent

Kakumanu VK, Bansal AK. Supercritical fluid technology in

pharmaceutical research. Businessbriefing: Labtech; 2004. p. 71-3.

Pasquali I, Bettini R, Giordano F. Solid-state chemistry and particle

engineering with supercritical fluids in pharmaceutics. Eur J Pharm Sci


Karanth H, Shenoy VS, Murthy RR. Industrially feasible alternative

approaches in the manufacture of solid dispersions: A technical report.

AAPS PharmSciTech 2006;7:87.

Spray drying From Wikipedia, the free encyclopedia. Available from: 08/03/2008.

Kawashima Y, Saito M, Takenaka H. Improvement of solubility and

dissolution rate of poorly water-soluble salicylic acid by a spray-drying

technique. J Pharm Pharmacol 1975;27:1-5.

Shinde AJ. Solubilization of poorly soluble drugs: A review. Available


drugs-review. 11/05/2008.

Micronization, Micron Technologies, Kent United Kingdom. Available

from: 14/04/2008.

Gran-U-LizerTM Technology, Modern Process Equipment Corporation,

Chicago, llinois 60623 U.S.A. Available from: http://www.mpechicago.

com/pharm/. 08/04/2008.

Jet-O-MizerTM Technology, Fluid Energy Processing and Equipment

Company, Telford, PA 18969. Available from: http://www.fluidenergype.

com/lit.htm. 12/04/2008.

Microfluidics. Available from:



Verheezen JJ, van der Voort Maarschalk K, Faassen F, Vromans H. Milling

of agglomerates in an impact mill. Int J Pharm 2004;278:165-72.

Airaksinen S, Antikainen O, Rantanen J, Yliruusi J. Advanced testing of

granule friability determined from size reduction data. Drugs Made in

Germany 2000;43:96-9.

Mishra BK, Thornton C. Impact breakage of particle agglomerates. Int

J Miner Process 2001;61:225-39.

Narayanan S. ‘Single particle breakage tests: A review of principles

and applications to commination modeling’. Bull Proc AIMM


Vogel L, Peukert W. Characterization of grinding relevant particle

properties by inverting a population balance model. 2002;19:149-57.

Hite M, Turner S. Oral Delivery of Poorly Soluble Drugs 400,

Pharmaceutical Manufacturing and Packing Source Summer ’03 issue.

Samedan Ltd; 2003.

Larran JM. Micronisation of pharmaceutical powders for use in

inhalation. Pharmaceutical Manufacturing and Packing. Sourcer

Spring’05 Issue, 2005.

Young L. Stable micro systems, Handling the powder flow problem.

Available from: March 2007.

Tservistas M, Levy MS, Lo-Yim MY, O'Kennedy RD, York P, Humphrey GO,

et al. The formation of plasmid dna loaded pharmaceutical powders

using supercritical fluid technology. Biotechnol Bioeng 2001;72:12-8.

Tservistas M, Scheper T, Freitag R. Supercritical fluid extraction

(SFE)-Novel strategies in the processing of biomaterials. In: Grabley

S, Thiericke R, editors. Drug discovery from nature. Berlin: Springer

Verlag; 1999. p. 106-13.

Sarkari M, Darrat I, Knutson BL. Generation of microparticles using

CO2 and CO2 -Philic Antisolvents. Am Inst Chem Eng J (AIChE)


Kipp JE. The role of solid nanoparticle technology in the parenteral

delivery of poorly water-soluble drugs. Int J Pharm 2004;284:109-22.

Violante MR, Fischer HW. Method for making uniformly sized particles

from water-insoluble organic compounds. 1989, US Patent 4,826,689

(May 2).

Chattopadhyay P, Gupta RB. Protein nanoparticles formation by

supercritical antisolvent with enhanced mass transfer. Am Inst Chem

Eng J (AIChE) 2002;48:235-44.

Nanosuspension drug delivery Technology and application - Nanotech -

Express Pharma Pulse. Available from: http://www.expresspharmapulse.

com. 24/02/2005.

Aulton ME. Pharmaceutics, The science of dosage form design. 2nd ed.

London: Churchill Livingstone; 2002. p. 113-38, 234-52.

Pinnamaneni S, Das NG, Das SK. Formulation approaches for orally

administered poorly soluble drugs. Pharmazie 2002;57:291-300.